CLDX - Celldex Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts1111
Avg. Estimate-1.21-1.05-4.8-3.37
Low Estimate-1.21-1.05-4.8-3.37
High Estimate-1.21-1.05-4.8-3.37
Year Ago EPS-0.6-0.81-14.48-4.8
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts1111
Avg. Estimate1.26M1.1M5.1M6M
Low Estimate1.26M1.1M5.1M6M
High Estimate1.26M1.1M5.1M6M
Year Ago Sales941k1.76M9.54M5.1M
Sales Growth (year/est)33.90%-37.60%-46.50%17.60%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-2.25-1.2-1.14-1.17
EPS Actual-0.6-0.81-1.4-0.84
Difference1.650.39-0.260.33
Surprise %73.30%32.50%-22.80%28.20%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.21-1.05-4.8-3.37
7 Days Ago-1.21-1.05-4.8-3.37
30 Days Ago-1.21-1.05-4.8-3.69
60 Days Ago-1.21-1.05-4.8-3.69
90 Days Ago-1.21-1.05-4.8-3.69
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCLDXIndustrySectorS&P 500
Current Qtr.-101.70%N/AN/A-0.00
Next Qtr.-29.60%N/AN/A0.08
Current Year66.90%N/AN/A0.03
Next Year29.80%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A